Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas Operating Margin 2010-2025 | HYPMY

Current and historical operating margin for Hypermarcas (HYPMY) over the last 10 years. The current operating profit margin for Hypermarcas as of March 31, 2025 is 12.54%.
  
Hypermarcas Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $1.20B $0.18B 15.23%
2024-12-31 $1.38B $0.34B 24.51%
2024-09-30 $1.50B $0.44B 29.27%
2024-06-30 $1.60B $0.50B 31.45%
2024-03-31 $1.63B $0.52B 31.82%
2023-12-31 $1.59B $0.50B 31.78%
2023-09-30 $1.62B $0.53B 32.88%
2023-06-30 $1.57B $0.51B 32.65%
2023-03-31 $1.50B $0.50B 32.96%
2022-12-31 $1.46B $0.48B 32.99%
2022-09-30 $1.35B $0.45B 33.09%
2022-06-30 $1.27B $0.42B 33.02%
2022-03-31 $1.17B $0.40B 33.70%
2021-12-31 $1.10B $0.37B 33.27%
2021-09-30 $1.02B $0.33B 32.58%
2021-06-30 $0.91B $0.30B 32.42%
2021-03-31 $0.82B $0.27B 32.52%
2020-12-31 $0.79B $0.26B 32.24%
2020-09-30 $0.81B $0.24B 29.40%
2020-06-30 $0.87B $0.24B 27.63%
2020-03-31 $0.92B $0.23B 24.54%
2019-12-31 $0.84B $0.28B 32.93%
2019-09-30 $0.84B $0.31B 36.39%
2019-06-30 $0.83B $0.31B 36.88%
2019-03-31 $0.84B $0.33B 39.40%
2018-12-31 $1.02B $0.34B 32.97%
2018-09-30 $1.06B $0.34B 31.89%
2018-06-30 $1.12B $0.36B 31.94%
2018-03-31 $1.13B $0.36B 32.18%
2017-12-31 $1.14B $0.36B 31.93%
2017-09-30 $1.11B $0.36B 32.43%
2017-06-30 $1.06B $0.35B 32.80%
2017-03-31 $1.03B $0.34B 32.88%
2016-12-31 $0.94B $0.31B 32.56%
2016-09-30 $0.39B $0.28B 71.50%
2016-06-30 $0.52B $0.27B 52.60%
2016-03-31 $0.70B $0.24B 34.24%
2015-12-31 $0.90B $0.27B 29.90%
2015-09-30 $1.72B $0.29B 17.08%
2015-06-30 $1.82B $0.29B 15.81%
2015-03-31 $1.92B $0.35B 18.17%
2014-12-31 $1.97B $0.36B 18.30%
2014-09-30 $1.96B $0.41B 20.78%
2014-06-30 $1.99B $0.46B 23.24%
2014-03-31 $1.95B $0.41B 21.01%
2013-12-31 $1.95B $0.39B 19.73%
2013-09-30 $1.98B $0.41B 20.53%
2013-06-30 $1.97B $0.39B 19.92%
2013-03-31 $1.98B $0.42B 21.27%
2012-12-31 $1.96B $0.36B 18.51%
2012-09-30 $1.78B $0.29B 16.23%
2012-06-30 $1.84B $0.22B 11.88%
2012-03-31 $1.96B $0.21B 10.48%
2011-12-31 $2.00B $0.25B 12.66%
2011-09-30 $2.21B $0.29B 13.16%
2011-06-30 $2.12B $0.35B 16.29%
2011-03-31 $1.96B $0.33B 16.74%
2010-12-31 $1.81B $0.32B 17.49%
2010-09-30 $1.65B $0.26B 15.62%
2010-06-30 $1.44B $0.24B 16.53%
2010-03-31 $1.22B $0.24B 19.22%
2009-12-31 $1.03B $0.20B 19.24%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.800B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $82.177B 31.61
Zoetis (ZTS) United States $67.587B 25.22
Daiichi Sankyo, - (DSNKY) Japan $46.942B 24.06
Takeda Pharmaceutical (TAK) Japan $45.374B 9.26
BeOne Medicines - (ONC) Cayman Islands $33.351B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.216B 0.00
Summit Therapeutics (SMMT) United States $21.775B 0.00
Merck (MKKGY) Germany $16.291B 11.94
Shionogi (SGIOY) Japan $14.748B 14.77
United Therapeutics (UTHR) United States $13.200B 11.42
Neurocrine Biosciences (NBIX) United States $12.699B 37.88
Orion OYJ (ORINY) Finland $11.709B 28.22
IPSEN (IPSEY) France $10.802B 0.00
Stevanato Group S.p.A (STVN) Italy $7.747B 47.37
Corcept Therapeutics (CORT) United States $7.563B 63.51
Grifols, S.A (GRFS) Spain $7.371B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.930B 0.00
Ionis Pharmaceuticals (IONS) United States $6.926B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.853B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 17.90
Soleno Therapeutics (SLNO) United States $4.239B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.651B 9.29
Crinetics Pharmaceuticals (CRNX) United States $2.642B 0.00
Procaps Group, S.A (PROCF) Luxembourg $2.534B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.495B 13.49
NewAmsterdam Pharma (NAMS) Netherlands $2.432B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.149B 0.00
Ocular Therapeutix (OCUL) United States $1.967B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.827B 0.00
ARS Pharmaceuticals (SPRY) United States $1.707B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.507B 22.45
Dyne Therapeutics (DYN) United States $1.458B 0.00
Evotec AG (EVO) Germany $1.378B 0.00
Guardian Pharmacy Services (GRDN) United States $1.282B 0.00
Harrow (HROW) United States $1.226B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.089B 0.00
Ardelyx (ARDX) United States $1.050B 0.00
Collegium Pharmaceutical (COLL) United States $0.999B 5.39
Akebia Therapeutics (AKBA) United States $0.988B 0.00
ProKidney (PROK) United States $0.954B 0.00
Enliven Therapeutics (ELVN) United States $0.920B 0.00
Xeris Biopharma Holdings (XERS) United States $0.870B 0.00
Cronos Group (CRON) Canada $0.775B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.710B 0.00
KalVista Pharmaceuticals (KALV) United States $0.665B 0.00
Relay Therapeutics (RLAY) United States $0.626B 0.00
Zevra Therapeutics (ZVRA) United States $0.615B 0.00
Organogenesis (ORGO) United States $0.584B 0.00
Xencor (XNCR) United States $0.566B 0.00
Theravance Biopharma (TBPH) United States $0.561B 0.00
Tourmaline Bio (TRML) United States $0.555B 0.00
USANA Health Sciences (USNA) United States $0.542B 10.90
Oruka Therapeutics (ORKA) United States $0.535B 0.00
Elite Pharmaceuticals (ELTP) United States $0.533B 0.00
Bioventus (BVS) United States $0.519B 13.17
Siga Technologies (SIGA) United States $0.475B 9.93
Savara (SVRA) United States $0.444B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.405B 10.95
Aquestive Therapeutics (AQST) United States $0.399B 0.00
AleAnna (ANNA) United States $0.341B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.328B 0.00
Nanobiotix S.A (NBTX) France $0.321B 0.00
Aldeyra Therapeutics (ALDX) United States $0.304B 0.00
Esperion Therapeutics (ESPR) United States $0.295B 0.00
Altimmune (ALT) United States $0.290B 0.00
Nektar Therapeutics (NKTR) United States $0.289B 0.00
Nature's Sunshine Products (NATR) United States $0.273B 17.82
Heron Therapeutics (HRTX) United States $0.267B 0.00
4D Molecular Therapeutics (FDMT) United States $0.243B 0.00
OmniAb (OABI) United States $0.238B 0.00
Galectin Therapeutics (GALT) United States $0.227B 0.00
Larimar Therapeutics (LRMR) United States $0.212B 0.00
MediWound (MDWD) Israel $0.199B 0.00
China SXT Pharmaceuticals (SXTC) China $0.183B 0.00
Lyell Immunopharma (LYEL) United States $0.176B 0.00
Profound Medical (PROF) Canada $0.171B 0.00
Aclaris Therapeutics (ACRS) United States $0.169B 0.00
Journey Medical (DERM) United States $0.166B 0.00
Lexeo Therapeutics (LXEO) United States $0.158B 0.00
Korro Bio (KRRO) United States $0.145B 0.00
Avita Medical (RCEL) United States $0.141B 0.00
Liminatus Pharma (LIMN) United States $0.132B 0.00
Protara Therapeutics (TARA) United States $0.122B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.121B 0.00
Inhibikase Therapeutics (IKT) United States $0.119B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.114B 0.00
Cassava Sciences (SAVA) United States $0.111B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cardiol Therapeutics (CRDL) Canada $0.106B 0.00
Avalo Therapeutics (AVTX) United States $0.097B 0.00
Surrozen (SRZN) United States $0.094B 0.00
Fractyl Health (GUTS) United States $0.091B 0.00
Achieve Life Sciences (ACHV) Canada $0.089B 0.00
Champions Oncology (CSBR) United States $0.088B 19.94
Metagenomi (MGX) United States $0.086B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Vivani Medical (VANI) United States $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Nutriband (NTRB) United States $0.079B 0.00
PMV Pharmaceuticals (PMVP) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Pyxis Oncology (PYXS) United States $0.068B 0.00
Wellgistics Health (WGRX) United States $0.062B 0.00
Rafael Holdings (RFL) United States $0.061B 0.00
Context Therapeutics (CNTX) United States $0.061B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.060B 44.56
DURECT (DRRX) United States $0.058B 0.00
BioNxt Solutions (BNXTF) Canada $0.055B 0.00
Telomir Pharmaceuticals (TELO) United States $0.054B 0.00
ElectroCore (ECOR) United States $0.054B 0.00
Unicycive Therapeutics (UNCY) United States $0.053B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.052B 0.00
Jupiter Neurosciences (JUNS) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
Klotho Neurosciences (KLTO) United States $0.046B 0.00
Plus Therapeutics (PSTV) United States $0.045B 0.00
Gain Therapeutics (GANX) United States $0.044B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
Enlivex Therapeutics (ENLV) Israel $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Mural Oncology (MURA) Ireland $0.032B 0.00
Scienture Holdings (SCNX) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Vivos Therapeutics (VVOS) United States $0.028B 0.00
FibroGen (FGEN) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Cosmos Health (COSM) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
Natural Alternatives (NAII) United States $0.023B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.022B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Lipocine (LPCN) United States $0.017B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.014B 0.00
Incannex Healthcare (IXHL) Australia $0.013B 0.00
ProPhase Labs (PRPH) United States $0.013B 0.00
Carisma Therapeutics (CARM) United States $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
TransCode Therapeutics (RNAZ) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
VYNE Therapeutics (VYNE) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 11.92
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 2.31
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00